SIGX1094R

· Signet Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SIGX1094R, covering 2025-09-08 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SIGX1094R in Patients With Advanced Solid Tumors [Phase 1]